Cartesian Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Cartesian Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cartesian Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cartesian Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $190k | 31k | 6.15 |
| 2025-03-31 | $208k | 16k | 13.18 |
| 2024-12-31 | $493k | 28k | 17.91 |
| 2024-09-30 | $183k | 11k | 16.12 |